Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane vs Anastrozole in Postmenopausal Breast Cancer
NCT00066573Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jun 2003
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by Canadian Cancer Trials Group. Started Jun 2003; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00066573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066573.